Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01163097 · ClinicalTrials.gov registry record · Phase 1
Study to Characterize the Effect of Heparin on Palifermin Activity
A Phase 1 study, sponsored by Swedish Orphan Biovitrum.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01163097 is a Phase 1 study that has completed, run by Swedish Orphan Biovitrum. The registered enrollment target is 44 participants.
The verdict
NCT01163097, a Phase 1 study, has completed, sponsored by Swedish Orphan Biovitrum.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of a continuous intravenous infusion of unfractionated heparin on the multiple-dose pharmacodynamics of palifermin in healthy adult subjects.
Interventions
- DRUG Palifermin
- DRUG Heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01163097
The ClinicalTrials.gov registry entry for NCT01163097 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Orphan Biovitrum, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Palifermin is the first listed.
NCT01163097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01163097 about?
NCT01163097 is a clinical study titled "Study to Characterize the Effect of Heparin on Palifermin Activity". The purpose of this study is to evaluate the effect of a continuous intravenous infusion of unfractionated heparin on the multiple-dose pharmacodynamics of palifermin in healthy adult subjects.
What is the current status of trial NCT01163097?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2010-07. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01163097?
The interventions under investigation include: Palifermin (DRUG), Heparin (DRUG).
Who is sponsoring clinical trial NCT01163097?
This trial is sponsored by Swedish Orphan Biovitrum, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.